Monday, May 23, 2016

New research may expand engineered T-cell cancer treatment

… folate-receptors and prostate-specific membrane antigen on the surfaces of cancer cells. Approximately … and colon cancers express folate receptors on their cellular surfaces. Prostate-specific membrane … nearly 90 percent of all prostate cancers. Other tumor-specific ligands developed by Low …

No comments:

Post a Comment